President Trump announced a sweeping agreement with Regeneron to reduce drug prices across its portfolio. The deal also includes major US investment and new medical advancements.
Posts tagged as “biotech investment”
Newly released federal exhibits are said to document an eight-year pattern of Jeffrey Epstein’s interest in cloning, genome engineering, and private biotech structuring. The records describe correspondence, investment activity, and alleged efforts tied to designer baby and human cloning ambitions.